About Maze Therapeutics

Maze Therapeutics is a biotechnology firm used to focus on translating genetic insights into new medicines. The company's translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, functional genomics, and an array of drug discovery approaches. and it also reveals modifier genes that confer protection and provide a deeper understanding of the target biology and how these targets can be targeted with drug therapies, enab

Company Highlights
Year Founded

2018

icon-altEmployees

122

Location (HQ)

USA

Since Last Funding

2 years 8 months

Monthly Website Visitors

3.8K

icon-altTotal Investment Amt

$400M

Last Funding Round

Series Unknown

icon-altMoM Headcount Growth

2.52%

icon-altYoY Headcount Growth

-3.17%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Biotechnology Research

Therapeutics